Cipher Digital CIFR Drops 879 Key Support at 1931 20260517 Tejon Ranch TRC Declines 161 Amid Market Weakness 20260515 Abbott ABT Up 093 Is There More Room to Run 20260519 Nebius NBIS Slips 913 Testing 18987 Support 20260518 MapLight Therapeutics Q1 2026 Earnings Wider Loss than Anticipated Yet Shares Climb on Pipeline Optimism GOOGL Q1 2026 Earnings EPS Misses Estimates as Cloud Growth Fails to Offset Ad Sluggishness Sachem SCCG Posts Record Q4 2025 EPS 003 Blows Past Estimates China Confirms Order for 200 Boeing Aircraft Signals Aviation as Key Area for US Cooperation NRx Pharmaceuticals Attracts Analyst Attention With Buy Rating and Ketamine Market Ambitions Samsung Chip Workers Potential Bonus Reaches 432000 Average Under Tentative Strike Agreement Tesla Surpasses Profit Expectations Despite Revenue Miss as Auto Margins Improve US Navy Official Confirms 14 Billion Arms Sale to Taiwan Paused Amid Iran Tensions Palo Alto Networks Outpaces Palantir by 60 YeartoDate Potential Index Rebalancing Questions Arise Markets Reassess Fed Policy Odds After Hot Inflation Data Rate Hike Possibility Emerges Leggett Platt Q1 2026 Earnings EPS Miss Weighs on Investor Sentiment MNSO Q4 2025 Earnings EPS Surges 88 Above Estimates Despite Revenue Silence Stock Slips LION Q1 2026 Earnings EPS Surge Drives DoubleDigit Stock Rally MNSO Q4 2025 Earnings Strong EPS Beat Amidst Operational Progress AirJoule Technologies Q1 2026 Earnings Significant EPS Miss Amid Development Stage Stock Rises on Strategic Hopes USANA USNA Stock Today Unchanged at 1804 Key Levels 20260518 Eagle EICA Trading at 2492 Key Decision Point 20260518 Block Deal Surge Signals Revival Hopes for Indias Equity Capital Markets Nuveen New NRK Slides 115 as Selling Pressure Mounts 20260515 Algorhythm Holdings RIME Stock Today Rallies 431 Resistance at 076 20260514 Valley VLYPO Stalls at 2510 Breakout or Breakdown 20260519 Nifty Hovers as Bond Yields FII Flows and Geopolitical Risks Set the Tone for DStreet This Week Kairos Pharma Ltd KAPA Q1 2026 Earnings Widerthanexpected loss and muted stock response amid preclinical focus